Gardnerella

Sialidase and Mucus Degradation#

G. vaginalis produces sialidase (neuraminidase), which cleaves sialic acid residues from mucin glycoproteins. Sialidase activity degrades the protective cervicovaginal mucus layer, exposing epithelial surfaces to secondary infection. Sialidase levels in vaginal fluid are a clinical marker for BV diagnosis and correlate with adverse pregnancy outcomes.

Biofilm Formation#

G. vaginalis is the primary architect of polymicrobial biofilms on the vaginal epithelium.

These biofilms are highly resistant to antibiotics (metronidazole, clindamycin) and host immune clearance, explaining the high recurrence rate of BV (>50% within 12 months).

Biofilm cells shed from the vaginal epithelium can re-seed infection, maintaining a chronic dysbiotic state.

Vaginolysin#

Produces vaginolysin, a cholesterol-dependent cytolysin that lyses human epithelial cells. Vaginolysin is human-specific, binding CD59 on human cells, which limits animal model studies.

Heavy Metal Exposure#

Vaginal Gardnerella abundance is associated with environmental heavy metal exposure, with Cadmium, Lead, and Mercury potentially promoting BV-associated Dysbiosis by suppressing protective Lactobacillus species.

Metalloestrogens (cadmium (Cd), nickel (Ni), lead (Pb)) may alter cervicovaginal immune responses and mucus composition in ways that favor Gardnerella colonization.^{[1]The Endobiota Study: Comparison of Vaginal, Cervical and Gut Microbiota Between Women with Stage 3/4 Endometriosis and Healthy ControlsAta B, Yildiz S, Turkgeldi E et al. · 2019Open reference 1 ↓}

Iron Acquisition#

G. vaginalis requires Iron for growth and competes with vaginal lactobacilli for this limiting nutrient. Menstrual blood provides periodic iron supplementation that can transiently favor Gardnerella expansion. Iron availability in the vaginal environment is a key determinant of the Lactobacillus-Gardnerella competitive balance.

Endometriosis Associations#

Gardnerella appears across multiple endometriosis microbiome studies. Enriched in cervical microbiota of stage 3/4 endometriosis patients (67.7% vs 36.8% of non-Lactobacillus taxa in sensitivity analysis).^{[1]The Endobiota Study: Comparison of Vaginal, Cervical and Gut Microbiota Between Women with Stage 3/4 Endometriosis and Healthy ControlsAta B, Yildiz S, Turkgeldi E et al. · 2019Open reference 1 ↓}

Detected within deep endometriotic lesion tissue alongside Lactobacillus, Enterococcus, and Pseudomonas.^{[2]Microbiome Profile of Deep Endometriosis Patients: Comparison of Vaginal Fluid, Endometrium and LesionHernandes C, Silveira P, Sereia AFR et al. · 2020Open reference 2 ↓} GnRH agonist treatment increased Gardnerella colony formation in endometriosis patients.^{[3]Molecular detection of intrauterine microbial colonization in women with endometriosisKhan KN, Fujishita A, Masumoto H et al. · 2016Open reference 3 ↓}

Decreased in stool of endometriosis patients, suggesting body-site-specific shifts.^{[1]The Endobiota Study: Comparison of Vaginal, Cervical and Gut Microbiota Between Women with Stage 3/4 Endometriosis and Healthy ControlsAta B, Yildiz S, Turkgeldi E et al. · 2019Open reference 1 ↓}

BV and Reproductive Health#

BV caused by G. vaginalis-dominant communities is associated with preterm birth, pelvic inflammatory disease, increased HIV acquisition, and post-surgical infections. The transition from Lactobacillus-dominant (CST I-III) to Gardnerella-dominant (CST IV) vaginal communities represents a clinically significant shift in vaginal ecosystem state.

BV treatment with antibiotics is often followed by recurrence due to biofilm persistence and re-establishment of the dysbiotic community.